Alumni raised $1.45B in 2022 - Download Free Report Now

IYIA Technologies

IYIA has developed a proprietary, clinically effective device, O2Misly, for treating slow healing foot wounds, primarily diabetic foot ulcers.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of IYIA Technologies plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About IYIA Technologies

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups


Companies We Work With